High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.

Published in:

European Journal of Haematology, 2013, v. 90, n. 6, p. 494, doi. 10.1111/ejh.12102

By:

• Gómez‐Almaguer, David;
• Tarín‐Arzaga, Luz;
• Moreno‐Jaime, Brizio;
• Jaime‐Pérez, José Carlos;
• Ceballos‐López, Adrián Alejandro;
• Ruiz‐Argüelles, Guillermo J.;
• Ruiz‐Delgado, Guillermo J.;
• Cantú‐Rodríguez, Olga Graciela;
• Gutiérrez‐Aguirre, Cesar Homero;
• Sánchez‐Cárdenas, Mónica

Publication type:

Article